The results indicate that, in vitro, 405- and 470-nm blue light produce dose dependent bactericidal effects on Pseudomonas aeruginosa and Staphylococcus aureus but not Propionibacterium acnes.
OPEN FILEAbstracts and summaries of several published papers on the use of blue light photobiomodulation.
OPEN FILEUnderstanding the function and relationship of different photoreceptors and their response to specific light parameters will lead to the development of reliable light-based therapies.
OPEN FILELow?level blue light can be a potential treatment for the prevention and reduction of tissue fibrosis, such as hypertrophic scar and keloids.
OPEN FILEIn conclusion, we observed that the blue LED light can be used to modulate metabolism and proliferation of human fibroblasts, and the effects in wound healing are particularly evident when studying the fibroblasts and keratinocytes co-cultures.
OPEN FILEThe observed inhibition of Gram-positive (MRSA) and Gram-negative (Salmonella) bacteria suggests the versatility of blue light in bacteria eradication...
OPEN FILEResults from these studies are expanding our understanding of the mode of action and functionality of blue light, allowing for improved options for acne patients.
OPEN FILEAppropriate doses of combined 405-nm and 880-nm phototherapy can kill Staphylococcus aureus and Pseudomonas aeruginosa in vitro, suggesting that a similar effect may be produced in clinical cases of bacterial infection.
OPEN FILEIn conclusion, endogenous photosensitization using blue light should gain considerable attention as an effective and safe alternative antimicrobial therapy for skin infections.
OPEN FILEaBL exhibits potential against pathogenic microorganisms and could help with the significant need for new antimicrobials in clinical practice to manage multidrug?resistant infections.
OPEN FILE